Azeliragon (TTP488)

Azeliragon (TTP488, PF-04494700) is an orally bioavailable small molecule that inhibits the receptor for advanced glycation endproducts (RAGE), which is an immunoglobulin-like cell surface receptor overexpressed in brain tissues of patients with AD.
Supplier Selleck Chemicals
Product # S6415
Sku # S6415-5mg
Pricing 5mg, $137.00
Feedback